11
Participants
Start Date
April 6, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Pro-GRID
Study participants will receive a single treatment of Pro-GRID therapy. After which, the participants would be able to resume standard therapy (after one week) and receive additional radiotherapy one month after Pro-GRID therapy, if recommended. Participants will be in the study for one year. Follow-up appointments will be scheduled at 1, 3, 6 and 12 months posttreatment, and may include a history and physical exam, labs and/or a CT scan and toxicity assessments.
Sibley Memorial Hospital, Washington D.C.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER